Benjamin Looker - General Counsel at Esperion Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Issuer Symbol
ESPR on Nasdaq
All Insider Reports
All Insider Reports

Benjamin Looker - trading volume in the past year for Esperion Therapeutics, Inc.

Holdings reported by Benjamin Looker for Esperion Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 384,216 $1,107,310 $2.88 20 Jan 2026 Direct
Stock Option (right to buy) 201,000 14 Mar 2025 Direct Common Stock

Transactions reported by Benjamin Looker for Esperion Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.